✦ LIBER ✦

Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation

✍ Scribed by Puig, Noemí; De La Rubia, Javier; Remigia, María J.; Jarque, Isidro; Martín, Guillermo; Cupelli, Luca; Sanz, Guillermo F.; Lorenzo, Ignacio; Sanz, Jaime; Martínez, Jesús A.; Jiménez, Carmen; Sanz, Miguel A.

Book ID: 125418721
Publisher: Informa plc
Year: 2006
Tongue: English
Weight: 161 KB
Volume: 47
Category: Article
ISSN: 1042-8194
DOI: 10.1080/10428190500527769

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous Busulfan Plus Melphalan Is a

Intravenous Busulfan Plus Melphalan Is a Highly Effective, Well-Tolerated Preparative Regimen for Autologous Stem Cell Transplantation in Patients with Advanced Lymphoid Malignancies

✍ Partow Kebriaei; Timothy Madden; Reza Kazerooni; Xuemei Wang; Peter F. Thall; Ce 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 232 KB

Genotypically nonidentical related donor

Genotypically nonidentical related donors for transplantation of patients with myelodysplastic syndromes: comparison with unrelated donor transplantation and autologous stem cell transplantation

✍ de Witte, T; Pikkemaat, F; Hermans, J; van Biezen, A; Mackinnan, S; Cornelissen, 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 131 KB

Comparative pharmacokinetic study of hig

Comparative pharmacokinetic study of high-dose etoposide and etoposide phosphate in patients with lymphoid malignancy receiving autologous stem cell transplantation

✍ Dorr, R T; Briggs, A; Kintzel, P; Meyers, R; Chow, H-HS; List, A 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 142 KB

Safety and efficacy of high-dose chemoth

Safety and efficacy of high-dose chemotherapy with autologous stem cell transplantation for patients with malignant astrocytomas

✍ Benjamin Chen; Tauseef Ahmed; Anney Mannancheril; Michael Gruber; Deborah L. Ben 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Abstract ## BACKGROUND Malignant astrocytomas are among the most resistant tumors to curative treatments. Mean survival without treatment is measured in weeks, and even with maximal surgery and radiation, the mean reported survival is < 1 year. The advent of supportive treatments and newer agen

Change of risk factors for treatment-rel

Change of risk factors for treatment-related mortality in children undergoing hematopoietic stem cell transplantation for malignant and nonmalignant diseases

✍ C. Peters; A. Lawitschka; A. Atarbaschi; T. Lion; U. Poetschger; G. Fritsch; G. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Bortezomib and High-Dose Melphalan as a

Bortezomib and High-Dose Melphalan as a Novel Conditioning Regimen for Patients With Poems Syndrome Undergoing Autologous Peripheral Blood Stem Cell Transplantation

✍ X. Tang; X. Shi; X. Hu; S. Xue; H. Qiu; Y. Han; L. Yan; H. Zhou; Y. Liu; B. Gu; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 58 KB